nVerses Capital’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
nVerses Capital's CABA Position: Q3 2026 in Review
nVerses Capital sold out of Cabaletta Bio (CABA) in Q3 2026, closing a stake of 20,286 shares — an estimated $63.1K sold.
nVerses Capital first reported a position in CABA in Q3 2024 and held it in 2 quarters. The position peaked at $63.1K in Q2 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- nVerses Capital reported no remaining Cabaletta Bio position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 20,286 Cabaletta Bio shares in Q3 2026, an estimated $63.1K.
- nVerses Capital first reported a position in Cabaletta Bio in Q3 2024 and held it in 2 quarters.
- nVerses Capital's Cabaletta Bio position peaked at $63.1K in Q2 2026.
- 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.